Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

Denver TMAU Test Lab survey click here
click to Read more/less

USA survey for anyone who wants to improve Denver TMAU test

begun : Dec22
end : no ending for now

A trainee genetic counselor is working at the Denver TMAU test lab. Probably as part of her training. As a project she wishes feedback on any aspect of the Denver TMAU test and process. You can fill in the survey and/or email her (email address is in survey). It's meant for USA people, but perhaps others can give their view too (as we have so few opportunities).

quote from her rareconnect post

"Hello all! I wanted to make you aware of a research study being conducted to better understand the experience and needs of individuals with trimethylaminuria with a goal of being able to create improved patient and healthcare provider education materials. Any participation is completely voluntary and all responses remain confidential. Feel free to use the contact information within the link with any questions or share the survey with others with TMAU."

see this post for more details

Sunday, May 31, 2009

Menstruation and Trimethylaminuria link in females with one FMO3 variant

This is an interesting 2007 paper by Dr John Cashman et al showing a possible link between menstruation and trimethylaminuria if the female had one or more mutants or polymorphs/variants of the FMO3 enzyme. It looks like the research was carried out in Japan, with Dr Cashman acting in a secondary role, probably including doing the DNA testing.

Transient trimethylaminuria related to menstruation


Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions. Herein, we describe data to support the proposal that menses can be an additional factor causing transient trimethylaminuria in self-reported subjects suffering from malodor and even in healthy women harboring functionally active flavin-containing monooxygenase 3 (FMO3).

FMO3 metabolic capacity (conversion of trimethylamine to trimethylamine N-oxide) was defined as the urinary ratio of trimethylamine N-oxide to total trimethylamine.

Self-reported Case (A) that was homozygous for inactive Arg500stop FMO3, showed decreased metabolic capacity of FMO3 (i.e., ~10% the unaffected metabolic capacity) during 120 days of observation. For Case (B) that was homozygous for common [Glu158Lys; Glu308Gly] FMO3 polymorphisms, metabolic capacity of FMO3 was almost ~90%, except for a few days surrounding menstruation showing <> 90%) metabolic capacity, however, on days around menstruation the FMO3 metabolic capacity was decreased to ~60–70%.

Together, these results indicate that abnormal FMO3 capacity is caused by menstruation particularly in the presence, in homozygous form, of mild genetic variants such as [Glu158Lys; Glu308Gly] that cause a reduced FMO3 function.

Full paper:Transient trimethylaminuria related to menstruation

The paper raises more questions than answers. It also goes to show how the textbook definition of TMAu (homozygous with FMO mutants) doesn't seem satisfactory. In the end, if someone says they smell of abnormal systemic smells at times (and they do), that would be the diagnosis and starting point. Usually the first step towards a TMAu diagnosis is the urine test, but it seems sensible to have the FMO3 DNA tested also, to see if there is at least a polymorph or wild type present, although even that may not be final since they may not know all polymorphs yet. FMO3 does seem to be a primary suspect in anyone who feels they have systemic body odor and maybe halitosis. However the tests cannot be deemed as 'final status' at the moment, sicne they may not know every FMO3 mutant/variant or be sure about the urine % for 'normal' etc (the % cut-off point has increased from about 50% to around 90% now). It's also unclear if there is an international agreed list of FMO3 variants, or if anyone is keeping an updated list. Also testers worldwide may use a different equation for the test, or not bother with the TMA-oxide part.

It also shows what can be achieved when real case studies are well constructed and close monitoring is used. It's unlikely in the near future that any expert would voluntarily do such an insightful TMAU test over 120 days. Sadly the medical system does not realise systemic body odor is possibly a common problem. It seems sensible to have the FMO3 DNA tested to see if there is at least a polymorph or wild type present if you have a longterm systemic body odor problem, although even that may not be final since they may not know all polymorphs yet. FMO3 does seem to be a primary suspect in anyone who feels they have systemic body odor and maybe halitosis.

keywords :
FMO3 mutant : a gene that has changed so that the normal transmission and expression of a trait is affected. Usually a bad thing. Usually 'severe'
FMO3 polymorphism : Difference in DNA sequence among individuals. Genetic variations occurring in more than 1% of a population would be considered useful polymorphisms for genetic linkage analysis.
FMO3 variant : A variant gene is usually a common very mild slightly different gene. Probably the same as a polymorphism.
homozygous : Possessing two identical forms of a particular gene, one inherited from each parent
heterozygous : Possessing two different forms of a particular gene, one inherited from each parent


Post a Comment